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Background: Aluminum oxide-based nanowhiskers (AO nanowhiskers) have been used in manufacturing processes
as catalyst supports, flame retardants, adsorbents, or in ceramic, metal and plastic composite materials. They are
classified as high aspect ratio nanomaterials. Our aim was to assess in vivo toxicity of inhaled AO nanowhisker
aerosols.
Methods: Primary dimensions of AO nanowhiskers specified by manufacturer were 2–4 nm x 2800 nm. The
aluminum content found in this nanomaterial was 30% [mixed phase material containing Al(OH)3 and AlOOH]. Male
mice (C57Bl/6 J) were exposed to AO nanowhiskers for 4 hrs/day, 5 days/wk for 2 or 4 wks in a dynamic whole
body exposure chamber. The whiskers were aerosolized with an acoustical dry aerosol generator that included a
grounded metal elutriator and a venturi aspirator to enhance deagglomeration. Average concentration of aerosol in
the chamber was 3.3 ± 0.6 mg/m3 and the mobility diameter was 150 ± 1.6 nm. Both groups of mice (2 or 4 wks
exposure) were necropsied immediately after the last exposure. Aluminum content in the lung, heart, liver, and
spleen was determined. Pulmonary toxicity assessment was performed by evaluation of bronchoalveolar lavage
(BAL) fluid (enumeration of total and differential cells, total protein, activity of lactate dehydrogenase [LDH] and
cytokines), blood (total and differential cell counts), lung histopathology and pulmonary mechanics.
Results: Following exposure, mean Al content of lungs was 0.25, 8.10 and 15.37 μg/g lung (dry wt) respectively for
sham, 2 wk and 4 wk exposure groups. The number of total cells and macrophages in BAL fluid was 2-times higher
in animals exposed for 2 wks and 6-times higher in mice exposed for 4 wks, compared to shams (p< 0.01,
p< 0.001, respectively). However no neutrophilic inflammation in BAL fluid was found and neutrophils were below
1% in all groups. No significant differences were found in total protein, activity of LDH, or cytokines levels (IL-6, IFN-
γ, MIP-1α, TNF-α, and MIP-2) between shams and exposed mice.
Conclusions: Sub-chronic inhalation exposures to aluminum-oxide based nanowhiskers induced increased lung
macrophages, but no inflammatory or toxic responses were observed.
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Shape modification of nanomaterials, e.g., tailoring them
to fiber-shaped nano-objects such as nanowires, nano-
whiskers, nanobelts and nanotubes is especially attractive
due to the unique properties that they acquire through
these alterations [1]. However, the physical properties of
the nanomaterials, such as shape or agglomeration state
may play an important role in nanoparticle toxicity [2,3].
Recently, an increasing number of studies have focused
attention on investigation of fiber-shaped or high aspect
ratio nanomaterials (HARNs) due to their asbestos-like
morphology and concern that these materials may have
similar mechanisms of toxicity [4-10]. HARNs include
materials such as carbon nanotubes (CNTs) that have
been most studied thus far. According to Institute of Oc-
cupational Medicine (IOM, Edinburgh, Scotland),
HARNs are classified “as part of the ‘one dimensional’
nanoscale building blocks; other one-dimensional parti-
cles include nanobelts and nanoribbons; these are nanos-
tructures with high surface area and high aspect ratio (of
greater than 10 to 1, length-to-diameter)” [7].
Key properties influencing pathogenicity of the fibers
are fiber dimensions, geometry of the fibers, their bioper-
sistence, high surface area, and surface reactivity [5,11].
It is well established that different types of asbestos fibers
have unequal pathogenicity. In the case of asbestos
fibers, a higher pathogenicity is associated with slower or
no clearance, “frustrated phagocytosis” and thus higher
biopersistence of fibers after exposure to long asbestos
fibers as opposed to short ones [4]. In addition, the
pathogenic potential of titanium dioxide (TiO2), that has
been considered to be biologically inert for many years,
was changed drastically when the shape of the material
was modified [12]. Long micron-sized nanobelts of TiO2
(>15 μm) were shown to be highly toxic particles caus-
ing an inflammatory response by alveolar macrophages.
Nanomaterials with higher aspect ratios have higher sur-
face areas and thus increased chance of cell interactions.
Due to increasing production of HARNs and subsequent
increasing potential for inhalation exposure, attention
should be paid to development of HARNs that are safe
by design before the products are introduced to the mar-
ket on a large scale [9,13].
Although many of these studies are focused on carbon
nanotubes, our study is specifically focused on the toxic
effects of commercially available aluminum oxide-based
nanowhiskers. Nanowhiskers are single metallic high as-
pect ratio structures in the nanometer scale, also called
nanowires or nanorods. Their diameter is in the nano-
meter range, however they can be more than a micron in
length. Nanowhiskers have unique optical, chemical, and
electrical properties. Many nanowhiskers are used for
their hydrophobic characteristics. Thus, they find use in
wrinkle-free, water or stain resistant clothing [14].Aluminum oxide nanomaterials have been used as cat-
alysts, catalyst supports, grain-growth inhibitors, heat-
transfer fluids (suspensions), and polymer nanocompo-
sites [15].
To date, not much research has been done on the be-
havior of metal oxide nanomaterials with a high aspect
ratio in biological systems. The majority of studies have
been conducted either in vitro or after instillation ex-
posure, however inhalation is the most relevant route of
exposure for evaluation of HARNs. Our study was
designed to characterize pulmonary toxicity after inhal-
ation exposure of AO nanowhisker aerosol. For gener-
ation of the aerosol we utilized a dry powder generation
system developed by our group based on acoustical dry
aerosol generator/elutriator [16,17], thus we eliminated a
large number of possible interactions of nanomaterials
with water or media.
Materials and Methods
Source of nanomaterial
Aluminum oxide nanowhiskers were purchased from
Sigma-Aldrich (St. Louis, MO, USA). The primary
dimensions of this material as reported by the manufac-
turer were 2–4 nm in diameter by 2800 nm in length.




Powder X-ray diffraction (XRD) was used to identify
crystalline phases present in the sample. XRD was per-
formed using a MiniFlex II X-ray diffractometer (Rigaku,
Woodlands, TX, USA). Transmission electron micros-
copy (TEM) (JEOL JEM-1230, Tokyo, Japan) was used to
measure the diameters of over 100 fibers to compare the
average diameter to manufacturer’s specifications. A
scanning electron microscope equipped with an energy
dispersive spectrometer (SEM-EDS) (Hitachi S-3400 N,
Tokyo, Japan) was used to image the nanowhisker aero-
sols passively collected on TEM grids in the whole body
exposure chamber. TEM was also used to assess agglom-
erate sizes of the nanowhisker aerosols generated in the
inhalation exposure chamber.
Surface characterization
Surface properties, surface area, and surface composition
of the AO nanowhiskers were assessed. Surface area
measurements were performed on an automated multi-
point BET surface area apparatus (Quantachrome Nova
4200e, Boynton Beach, FL, USA) using nitrogen gas as
the adsorbent. Samples were degassed at 300°C for 5 hrs
under vacuum before the analysis. X-ray photoelectron
spectroscopy (XPS) was used to probe the surface
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(Ultra-Axis XPS system, Kratos, Manchester, UK).
Dissolution measurements
The dissolution of AO nanowhiskers was measured in
artificial lysosomal fluid (ALF) (pH 4.5) and Gamble’s so-
lution (pH 7.4) using inductively coupled plasma - op-
tical emission spectroscopy (ICP-OES, Varian 720 ES,
Walnut Creek, CA, USA). The ALF simulates the phago-
lysosomal composition and pH of alveolar and interstitial
macrophages and the Gamble’s solution is used to mimic
the interstitial fluid in the lungs [18]. Simulated bio-
logical fluids were prepared as previously described [19].
The nanowhisker solutions were incubated up to 4 wks
at 38°C. The final solutions were filtered (0.2 μm, Millex-
LG, Millipore, Billerica, MA, USA) and centrifuged for
30 min at 44,912 × g in order to remove materials that
were not dissolved, and analyzed by ICP-OES.
Animals
Male C57Bl/6 J mice (6 wks old) were obtained from
The Jackson Laboratory (Bar Harbor, ME, USA) and
acclimatized for 12 days prior to exposures. They were
housed in our vivarium in polypropylene, fiber-covered
cages in HEPA-filtered Thoren caging units (Hazelton,
PA, USA) in the Pulmonary Toxicology Facility at the
University of Iowa during the study. Food (sterile Teklad
5% stock diet, Harlan, Madison, WI, USA) and water
(via an automated watering system) was provided ad
libitum. A 12-hr light–dark cycle was maintained in the
animal room. The average body weight of mice at the
end of acclimatization time was 23.7 ± 0.2 g. Mice were
monitored during the whole study, weighed weekly and
observed for any behavioral changes or clinical symp-
toms. All protocols used in this study were approved by
the Institutional Animal Care and Use Committee and
were compliant with NIH guidelines. At the time of
necropsy the average body weights were 24.1 ± 0.2 g
after 2-wk exposure and 25.0 ± 0.4 g after 4-wk expos-
ure. Control mice (exposed to laboratory air) at the time
of necropsy weighed 24.5 ± 0.4 g.
Generation of dry aerosol and inhalation
exposure of mice
The aerosol generation and exposure system is dia-
grammed in Figure 1. A dry aerosol of AO nanowhiskers
was generated using an acoustical dry aerosol generator/
elutriator (ADAGE) [16]. The ADAGE was adapted to
include an electrically grounded aluminum elutriator
(6.3 cm I.D. x 30.5 cm) to reduce aerosol losses within
the column by minimizing static charge effects. Both
ends of the aluminum column were covered with latex
sheets that were stretched taut and held in place by rub-
ber bands. The bottom of the column was placed overan 8-cm speaker. Speaker output was produced by
adjusting an amplifier to produce an output of 7 V, and
adjusting two frequency modulators to produce 10 Hz
and 1 Hz overlapping signals. The ADAGE was also
adapted with the addition of a venturi aspirator at the
exit to enhance deagglomeration. The aspirator was
designed as described by Cheng et al. [20] with a 1.5-mm
nozzle diameter and operated such that a 14 L/min
main flow rate of filtered, compressed air through the as-
pirator produced a 4 L/min suction flow rate. As shown
in Figure 1, this suction air was pulled through a HEPA
filter and into the ADAGE column via a port 2 cm from
the bottom where it caused acoustically suspended AO
nanowhiskers to exit a port 2 cm from the top and into
the aspirator. The aerosol was transferred through a 20-
mCi 63Ni source to remove static charge and into a 65 L
dynamic whole-body exposure chamber [21]. Based on
trials conducted before the animal exposures, loading
200 mg of AO nanowhisker powder on the bottom latex
sheet of the column was sufficient to produce the desired
aerosol concentration in the chamber (3.3 mg/m3) for
2 hrs. Thus, nanowhisker loading was repeated each
2 hrs during exposure. Furthermore, after adding a new
bolus of powder the aerosol was made to bypass the
chamber for 10 min to avoid administering a large spike
in concentration observed during this time period. The
size distribution of the generated dry aerosol during ani-
mal exposures was measured using a scanning mobility
particle sizer (SMPS, TSI Inc., Shoreview, MN, USA,
model 3071A electrostatic classifier and model 3010 con-
densation particle counter, measuring particle diameters
in 105 size channels between 7.4 - 289 nm). To assure
we were measuring the full range of particulates gener-
ated by our system, we also used a portable aerosol spec-
trometer (PAS, Grimm Technologies, Inc. Douglasville,
GA, USA model 1.108, measuring particle diameters in
15 size channels between 0.3 – 20 μm). Combined mea-
surements of SMPS and PAS showed that the majority
of the particles were less than 300 nm in diameter
therefore the subsequent size distribution was based on
the SMPS measurements.
The mass concentration of the aerosol in the
whole-body chamber was measured gravimetrically
every 2 hrs using 47-mm fiberglass filters (Whatman,
Middlesex, UK) that were placed in stainless steel
holders directly in line with the exhaust air flow of
24 L/min. Filters were weighed using a calibrated
Mettler MT5 six-place balance (Mettler-Toledo, Inc.,
Columbus, OH, USA) placed in a dedicated climate-
controlled room. Daily average concentrations ranged
from 2.2 – 4.6 mg/m3.
Control animals were exposed in an adjacent labora-
tory to HEPA-filtered air in an identical whole-body ex-
posure chamber and to a comparable sound pressure
Figure 1 Schematic of generation and exposure system used for AO nanowhiskers. Acoustical dry aerosol generator/elutriator (ADAGE) was
used to generate AO nanowhisker aerosol. Particle-laden air was pulled to the custom whole-body chamber through venturi aspirator and particle
charge neutralizer.
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eration and exposure.
Mice were exposed in a sub-chronic experimental de-
sign for 4 hrs/day, 5 days/wk for 2 or 4 wks and necrop-
sied within one hour after the last exposure (Figure 2).
The average mass concentration of AO nanowiskers in
the chamber was 3.3 ± 0.6 mg/m3.
Bronchoalveolar lavage fluid and blood analyses
After the exposure, mice were euthanized with an overdose
of isoflurane, cervical dislocation and exsanguination. The
lungs from 5 mice were lavaged, in situ, three times with
approximately 1 mL of sterile saline (0.9% sodium chloride
solution, Baxter, Deerfield, IL, USA). The recovered fluid
was centrifuged, the total white blood cells were counted
using a hemocytometer and the supernatant was stored at
−80°C for later analyses. For differential cell counts, resus-
pended cells in Hank’s balanced salt solution were spun
(800 x g, 3 min, Cytospin 4, Thermo Shandon, Thermo Sci-
entific, Waltham, MA, USA) onto microscope slides and
air-dried. The slides were stained using HEMA 3 stain set,
then 400 cells were counted to enumerate macrophages,
neutrophils and lymphocytes. Total protein level and
lactate dehydrogenase (LDH) activity in BAL fluid superna-
tants were determined using a Bradford protein assay (Bio-
Rad Laboratories, Inc., Hercules, CA, USA) and a commer-
cially available LDH kit (Roche Diagnostics, Penzberg,
Germany). Multiplexed fluorescent bead-based immu-
noassays (Bio-Rad Laboratories, Inc., Hercules, CA, USA)were utilized to measure interleukin (IL)-6, IL-12(p40),
tumor necrosis factor (TNF)-α, granulocyte macrophage
colony stimulating factor (GM-CSF), keratinocyte-derived
cytokine (KC), monocyte chemotactic protein (MCP)-1,
and macrophage inflammatory protein (MIP)-1α, MIP-2
and interferon (IFN)-γ.
Blood samples were collected in EDTA-containing
MultivetteW tubes (SARSTEDT AG & Co., Nümbrecht,
Germany) and analyzed using automatic hematology an-
alyzer (Sysmex XT-2000i, Kobe, Japan).
Elemental analysis in tissues and BAL fluid
Lung, heart, spleen and liver tissues from 6 mice in
each group were stored at −80°C after removal. Tis-
sues were lyophilized for approximately 16 hrs at
1.3 × 10-1 mBar and −50°C (Labconco Corp., Kansas
City, MO, USA) and then weighed. The tissues were
digested in a HotBlock™ digestion system (Environ-
mental Express, Mt. Pleasant, SC, USA) at 95-98°C
using mixtures of high purity concentrated nitric acid
and hydrochloric acid (Optima grade, Fisher Scientific,
Pittsburgh, PA, USA). Metal analysis was performed
using ICP-OES (Varian 720 ES, Walnut Creek, CA,
USA) with a method detection limit for Al of 0.0016 μg/
g lung (dry wt). BAL fluid was centrifuged at 44,900 x
g for 30 min and Al ion concentration in the super-
natant was determined by inductively coupled plasma-
mass spectrometry (ICP-MS, X Series, Thermo Scientific,
Waltham, MA, USA).
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Figure 2 Experimental design for this inhalation study of AO nanowhiskers.
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Pulmonary mechanics measurements were performed in
mice exposed to AO nanowhiskers, sham-exposed mice
as well as mice exposed to 3 U/kg bleomycin. The mice
exposed to bleomycin by intratracheal instillation served
as positive controls [22] and were necropsied 21 days
post exposure.
To measure pulmonary mechanics, mice were admi-
nistered 90 mg/kg of pentobarbital sodium (Ovation
Pharmaceuticals, Inc. Deerfield, IL, USA) by intraperito-
neal injection (n = 5 mice) followed by tracheotomy using
a tracheal cannula with luer adapter (1.3 mm, length
20 mm, Harvard Apparatus, Holliston, MA, USA). Mice
were then connected to a computer-controlled small ani-
mal ventilator (flexiVent, SCIREQ, Montreal, QC,
Canada) set at a frequency of 150 breaths/min, a tidal
volume of 10 mL/kg and a positive end-expiratory pres-
sure of 2 – 3 cm H2O. The forced oscillation technique
was used to assess Dynamic Resistance (R, the level of
constriction in the lungs) and Dynamic Compliance (C,
the ease with which the lungs can be extended) measure-
ments. From these two measurements Dynamic Ela-
stance (E) (the inverse of the Compliance, E = 1/C) wascalculated by flexiVent software (version 5). These mea-
surements R, C, and E represent parameters of the whole
respiratory system (airways, lung and chest wall). To
measure airway hyper-reactivity, mice were challenged
with increasing methacholine aerosols (1, 3, 10 and
30 mg/mL), generated with an in-line nebulizer (10 sec)
directly through the canulated trachea. Response to
methacholine was determined every 30 sec for 5 min, en-
suring the measurement parameters stabilized. The lungs
were inflated to total lung capacity after each methacho-
line dose, to prevent atelectasis and to return the mea-
surements back to baseline.
Histopathology of lung tissues
A subset of mice (n = 5 per group) were not lavaged but
were perfused through the heart with saline and their
lungs were fixed using 10% Zn formalin. The lungs were
then embedded in paraffin blocks, sectioned at 5 μm and
stained with hematoxylin and eosin (H & E). Light field
microscopy was used to evaluate stained sections of lung
tissues with the focus on presence or absence of inflam-
matory cells infiltrates, lymphoid agglomerates or
fibrosis.
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Data from controls and AO nanowhisker-exposed mice
were compared using t-tests for equal and unequal vari-
ance. A p-value less than 0.05 was considered significant.
Area under the curve (AUC) was calculated for pul-
monary mechanics measurements and R, C and E were
compared using analyses of variance (ANOVA) for re-




Crystalline phases present in the AO nanowhiskers were
determined from powder XRD. These data are shown in
Figure 3A. The manufacturer’s stated formula for the
nanowhiskers is Al2O3. Attempts to match the XRD pat-
tern of the nanowhiskers with Al2O3 phases were unsuc-
cessful, however, the XRD pattern of the AO nanowhiskers
aligned well with XRD patterns of aluminum hydroxide,
Al(OH)3, and aluminum oxyhydroxide, γ-AlOOH. Based
on the XRD patterns, it appears that the aluminum oxide
nanowhiskers are a mixture of bayerite (Al(OH)3) and
boehmite (AlOOH) [23]. Additionally, it was determined






















Figure 3 Characterization of the AO nanowhiskers. XRD patterns of the
bayerite and boehmite (A), X-ray photoelectron spectrum of the nanowhisk
onto TEM grid (C), and size distribution of nanowhisker diameters (D).Surface composition examination using XPS (Figure 3B)
showed binding energy peaks in the Al2p, Al2s, C1s,
and O1s regions of the photoelectron spectrum with
values of 74, 119, 285, and 532 eV, respectively. The
Al2p peak at 74 eV lies within the binding energy
region for aluminum oxides and hydroxides, where the
hydroxides have peaks close to 74 eV [24]. The O1s
peak position at 532 eV is indicative of surface hydroxyl
groups, Al-OH [25]. The peak at 285.0 eV is due to ad-
ventitious carbon on the nanowhiskers surface, a com-
mon feature seen for surfaces exposed to the ambient
environment.
Figure 3C shows a TEM image of agglomerated nano-
whiskers deposited on a TEM grid from a methanol solu-
tion. The diameters of individual fibers were measured
to obtain a size distribution. As shown in Figure 3D, the
size distribution is narrow with an average diameter of
3 ± 0.6 nm based on the measurement of over 100 fibers.
This result agrees well with the manufacturer’s specified
diameter of 2–4 nm. The length of the nanowhiskers
could not be measured precisely because the nanowhis-
kers were tangled as can be seen in Figure 3C. Although
the length of whiskers reported by the manufacturer to
be 2800 nm, they appeared to range from 50 to 300 nm.









































nanowhiskers compared to XRD patterns for two reference materials,
ers (B), TEM image of AO nanowhiskers deposited from methanol
Table 1 Summary of physicochemical properties of AO
nanowhiskers and generated aerosol
AO nanowhiskers
Structure Crystalline
Phases Al(OH)3 and γ-
AlOOH
Primary diameter1 3 ± 0.6 nm
Length1 ~ 50 – 300 nm
Surface functionalization O, O-H and H2O
BET surface area 320 ± 4 m2/g




Exposure concentration 3.3 ± 0.6 mg/m3
1 Primary diameter and length as measured by TEM in our laboratory. The
length of the nanowhiskers could not be measured precisely since they
appeared as tangled bundles. The length reported by manufacturer was
2800 nm.
2 Geometric mean mobility diameter (GM) and geometric standard distribution
(GSD).
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where the BET isotherm is most linear. This yielded a
surface area of 320 ± 4 m2/g for these nanowhiskers. Phy-
sicochemical properties of AO nanowhiskers and the
generated aerosol are summarized in Table 1.
Dissolution in artificial lung fluids
The propensity of AO nanowhiskers to dissolve into ions
was investigated in solutions designed to represent dis-
solution in the airway surface liquid or in the macro-
phage phagolysosome. ALF with a relatively low pH of
4.5 contains a large amount of citric acid that is sup-
posed to simulate the role of proteins produced by
macrophages to dissolve foreign materials. Gamble’s so-
lution with the pH of 7.4, simulates the pH environment
found in the interstitial fluid in the lungs. As can be seen
from Figure 4, 9% of AO nanowhiskers were dissolved in
Gamble’s solution after 2 wks and about 15% after 4 wks.





















Time in the solution, days
Gamble's
ALF
Figure 4 Dissolution kinetics of AO nanowhiskers in simulated
biological fluids.dissolution in ALF buffer, where almost 35% of nano-
whiskers were dissolved in 2 wks and about 58% in 4
wks.Aerosol characterization
AO nanowhisker aerosols collected in the exposure
chamber were imaged using TEM and SEM (Figure 5A
and 5B). Figure 5A is a TEM image of a nanowhisker ag-
glomerate with protruding whiskers. SEM-EDS analysis
(Figure 5C) of the agglomerates detected Al at its charac-
teristic X-ray energy within the aerosols. The size distri-
bution of the nanowhisker agglomerates comprising the
aerosol in the exposure chamber had a geometric mean
mobility diameter (GM) of 150 nm and a geometric
standard deviation (GSD) of 1.6 (Figure 6).Dosimetry of AO nanowhiskers in the tissues and
BAL fluids
Retained Al in the lung tissues was determined by ICP-
OES (Table 2). The mass of Al in sham-exposed mice
was very low (0.25 ± 0.17 μg/g lung (dry wt)). Both
groups of mice exposed to AO nanowhiskers for 2 or 4
wks had significantly higher (p< 0.001) mass of Al in
the lung tissues. The mass of Al in lung tissues from
mice exposed for 2 wks and 4 wks was 8.10 ± 0.79 and
15.37 ± 0.31 μg/g lung (dry wt), respectively. These
values correspond to 0.24 μg Al/mouse for 2 wk-exposed
and 0.51 μg Al/mouse for 4-wk exposed animals.
We estimated the deposited dose as a function of mi-
nute volume of 25 mL/min, an aerosol concentration of
3.3 mg/m3 and a deposition coefficient of 0.10 in the
tracheo-bronchiolar and pulmonary region [26,27]. Using
this calculation and considering that the AO nanowhis-
kers were 30% Al by XRD and ICP-OES, we estimated
that 5.88 μg Al/mouse was delivered to the lungs after
exposure to AO nanowhiskers for 2 wks and 11.76 μg
Al/mouse after 4 wk exposure. Our estimation did not
take into the consideration clearance of particulates via
the mucociliary escalator to the trachea or gastrointes-
tinal tract, clearance of particulates to lymphatic system,
nor translocation of nanomaterial to other organs. We
found that there was 4% of retained Al in the lungs from
our estimated Al dose.
We determined the levels of Al ions in particle- and
cell-free BAL fluid by ICP-MS, however the amounts of
Al3+ were very low and not different between shams and
exposed groups (0.55 μg/L ± 0.40, 0.67 μg/L ± 0.61 and
0.70 μg/L ± 0.28 in shams and in mice exposed for 2 wks
and 4 wks, respectively). These results show that little
AO dissolved in lung fluids. The levels of Al in hearts,
spleens and livers were not significantly different be-
tween AO-nanowhisker-exposed groups and shams.
Figure 5 AO nanowhiskers collected in the exposure chamber. A TEM image (A), SEM image (B) and SEM EDS map (C) of the same region as
shown in Figure 5B. Scale bars in 5B and 5 C represent 2.4 μm. Red color represents signal collected at characteristic X-ray energy for Al metal.
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As shown in Table 3, exposure to dry aerosols of AO nano-
whisker for 2 or 4 wks caused significantly higher (p< 0.01
and p< 0.001, respectively) recruitment of total cells in
BAL fluid (171.6±19.7 x 103 and 440.3±33.6 x 103 cells/
mouse, respectively) as compared to control mice (74.0 xDiameter (nm)
























GM = 150 nm
GSD = 1.6
Figure 6 Particle size distribution of AO nanowhisker aerosols
generated by ADAGE to the whole-body exposure chamber.
The geometric mean mobility diameter(GM) of aerosolized AO
nanowhiskers was 150 nm with geometric standard deviation (GSD)
1.6. Measurement was performed using SMPS sampling exhaust flow
from the chamber.103±7.9 cells/mouse). This elevation was represented
mainly by significant increases of macrophages in BAL fluid
in animals exposed to the AO nanowhiskers for 2 wks (2-
fold increase) or 4 wks (6-fold increase) in comparison to
controls (Figure 7). The number of neutrophils in BAL fluid
per mouse was significantly increased in AO nanowhisker-
exposed animals for 2 wks (1.5 x 103±0.3) compared to
sham-exposed mice however this increase was not biologic-
ally meaningful. Such numbers of neutrophils in BAL fluid
are often seen in controls or naïve mice (sentinels).
Values of total protein as well as LDH activity in BAL
fluid were normal and not elevated in comparison to
controls (Table 3). Similarly, none of the measured cyto-
kines (IL-6, IL-12(p40), TNF-α, GM-CSF, KC, MCP-1,
MIP-1α, IFN-γ and MIP-2) were different from controls.
Most of measured cytokines were below the limits of de-
tection, except IL-12(p40), but the concentrations were notTable 2 Al concentration in lung tissue of shams and AO




2 wks 4 wks
Lung tissue, μg/g lung
(dry weight)
0.25 ± 0.17 8.10 ± 0.79*** 15.37 ± 0.31***
Values are expressed as mean and standard error; ***p< 0.001 significantly
different from shams.
Table 3 Total number of cells, concentration of total





2 wks 4 wks
Total cells/mouse, n x 103 74.0 ± 7.9 171.6 ± 19.7 ** 440.3 ± 33.6 ***
Total protein, μg/mL 107.7 ± 4.7 108.0 ± 1.5 101.2 ± 2.7
LDH activity, U/L 180± 18 146 ± 17 191 ± 10
Values are expressed as mean and standard error; *p< 0.05, **p< 0.01,
***p< 0.001 significantly different from sham-exposed animals.
Table 4 Blood parameters in shams and mice exposed to





2 wks 4 wks
White blood cells × 103/μL 3.09 ± 0.67 3.78 ± 0.86 3.39 ± 1.02
Red blood cells × 106/μL 11.16 ± 0.31 10.48 ± 0.36 10.48 ± 0.44
Hemoglobin, g/dL 17.10 ± 0.45 16.33 ± 0.59 16.67 ± 0.49
Hematocrit, % 54.51 ± 1.22 50.96 ± 1.87 50.88 ± 1.61
Neutrophils × 103/μL 0.72 ± 0.30 0.55 ± 0.10 0.55 ± 0.19
Lymphocytes × 103/μL 2.05 ± 0.37 2.76 ± 0.71 2.46 ± 0.73
Monocytes × 103/μL 0.28 ± 0.05 0.38 ± 0.08 0.32 ± 0.10
Eosinophils × 103/μL 0.04 ± 0.01 0.09 ± 0.03 0.06 ± 0.02
Basophils × 103/μL 0.009 ± 0.004 0.006 ± 0.004 0.001 ± 0.001
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exposed groups for 2 or 4 wks (38.2 ± 3.5, 37.2 ± 2.3, and
34.7 ± 1.2, respectively).
The total number of white blood cells, red blood cells,
neutrophils, lymphocytes, monocytes, eosinophils, baso-
phils, and values of hemoglobin and hematocrit were not
significantly different between controls and AO
nanowhisker-exposed mice (Table 4).
Lung histopathology and pulmonary mechanics
measurements
Histopathology evaluation of lung tissues stained with
H&E did not reveal any signs of inflammatory cells infil-
trates, lymphoid agglomerates, or fibrosis. All lung tissues
from control mice or mice exposed to AO nanowhiskers
for 2 or 4 wks were evaluated as normal (Figure 8). These
results were consistent with pulmonary mechanics para-
meters such as resistance, elastance and compliance. All
these parameters were assessed in mice challenged with
increasing doses of methacholine aerosol. Comparison of
means of AUC between controls and AO nanowhiskers-
exposed mice using ANOVA for repeated measuresExposure to AO nanowhiskers
































Figure 7 Number of differential cells in BAL fluid in sentinels,
mice exposed to laboratory air (shams) or mice exposed to AO
nanowhiksers for 4 hrs/day for 2 or 4 wks (at daily
concentration of 3.3 mg/m2); Data are expressed as mean± SE;
*p< 0.05, **p< 0.01, ***p< 0.001 significantly different from shams.showed no significant differences (Figure 9A and 9B).
Thus, inhalation exposure to AO nanowhiskers did not
produce clinically significant remodeling of the airway or
airway hyperreactivity of the mice. On the other hand,
mice exposed to the positive control, bleomycin, devel-
oped fibrotic changes and significantly increased pul-
monary resistance and decreased compliance measured
after methacholine challenge as compared to controls
(Figure 9A and B).Discussion
Our study is one of few to use a dry powder generation
system for inhalation exposure to HARNs. Generation
and exposure systems utilizing dry aerosols are the best
options to recreate human exposure conditions, since
there have been many challenges with characterization of
nanomaterials in different milieu (e.g. water or culture
media). These challenges are even more pronounced for
HARNs mainly due to the higher aspect ratio of fibers in
comparison to other nanomaterials as well as increased
surface area that can lead to higher surface interactions
than other nanomaterials [7].
The Al3+ concentration detected in the lungs of mice
after 4 wk exposure to Al nanowhiskers was 0.505 μg Al/
mouse. Considering that 30% of AO nanowhisker mass
is Al, the mouse burden of AO nanowhiskers would be
1.68 μg AO nanowhiskers/mouse, which corresponds to
the lung burden accumulated by a 70 kg person exposed
to a concentration of 1 mg/m3 for 44 hrs (assuming
breathing 15 breaths/min, 600 mL/breath, and a pul-
monary deposition fraction for 150 nm particles of 0.2
[27] and delivered AO nanowhisker dose to human
4712 μg). Extrapolating mass of AO nanowhiskers per al-
veolar epithelial surface area for mouse (0.05 m2) and
the human (102 m2) [28], the mouse burden would be
34 μg/m2 and human burden would be 46 μg/m2.
Figure 8 Microslides of lung tissue with H&E staining from control mice (A), mice exposed to AO nanowhiskers for 2 (B) or 4 wks (C).
Figures D and E show localization of particulates in lung epithelium and macrophages in the lungs from mice exposed to AO nanowhiskers (dark
field images, magnification 100 ×).
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ation process applied during this study was characterized
by an SMPS and TEM. Those results suggest that this dry-
dust generation method was capable of producing a size
distribution comparable to those produced in our previous
studies [18,29-32] in which a powder suspension was nebu-
lized and the droplets dried prior to entry into the cham-
ber. Our previous efforts to use sonic energy to disperse
nanopowders were not as successful when applied to other
nanopowder types and without the alterations applied dur-
ing this study [33]. The addition of the venturi aspirator
and static-charge grounding strap to an aluminum (rather
than plastic) elutriator were adaptations to the ADAGE
that resulted in a consistent output of nanowhisker
agglomerates with a GM of 150 nm.
We attempted to characterize the particles in the lungs
after exposure using bright and dark field microscopy as
well as TEM-EDS. However, we were unable to locate
particles in lung tissue using TEM. This might be attrib-
uted to low retained doses of AO nanowhiskers in thelungs and low amount of Al in the AO nanowhiskers,
thus it is possible that Al ion concentrations in the lung
tissues were too low to produce a signal in TEM-EDS.
As with our previously studied materials [18,29,31],
characterization of the nanomaterials confirmed that
characterization data provided by manufacturers needs to
be independently determined due to batch to batch variabil-
ity and the fact these materials are not always characterized
using state-of-the-art instrumentation. Based on the XRD
patterns, it appears that AO nanowhiskers were not a pure
aluminum oxide phase such as Al2O3 but instead were a
mixture of bayerite (Al(OH)3) and boehmite (AlOOH) [23].
Thus, complete and independent characterization of mater-
ial used for toxicity evaluation is essential [23].
Many recent studies have related bioavailability and
subsequent toxicity of nanomaterials to the ability of the
nanomaterial delivered to biological or environmental
milieu to release soluble metal ions to proximate cells or
organisms [34-36]. Our previous study found this asso-
ciation between nanoparticle toxicity and dissolution
Figure 9 Measurement of pulmonary mechanics in mice exposed to AO nanowhiskers. Pulmonary mechanics measurements expressed as
resistance and compliance in sham- and AO nanowhisker-exposed mice after increasing concentration of methacholine (1, 3, 10 and 30 mg/mL).
The mean and SE of resistance and compliance versus methacholine concentrations (A). The individual and mean area under the curve (AUC)
versus all increasing methacholine concentrations (B).
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of nanowhiskers were dissolved in ALF buffer (pH 4.5) in 2
wks and 58% in 4 wks. About 15% of AO nanowhiskers
dissolved in Gamble’s solution (pH 7.4) which represents
extracellular fluid (Figure 4) in 4 wks. We found that it was
difficult to dissolve AO nanowhiskers even in concen-
trated nitric acid. The observation of relatively high dis-
solution of AO nanowhiskers in ALF but low dissolution
in vivo suggests that AO nanowhiskers undergo ligand-
promoted dissolution in the simulated biological buffers
due to the presence of citric acid [37].
In ligand–promoted dissolution, ligands form surface
complexes that can polarize metal-oxygen bonds, thus facili-
tating the detachment of metal species from the surface.
Ligands are capable of forming surface chelates, i.e., bi- or
multi-dentate ligands such as oxalate or citrate, can facilitate
these interactions and enhance the dissolution of aluminum
oxide [38]. It has been shown that citrate adsorbs to
aluminum oxyhydroxide surface in a predominantly inner-
sphere manner which facilitates the dissolution of this min-
eral [39]. Citrate is a molecule of both environmental and
biological importance since it is present in many naturally-occurring systems and in blood plasma at a concentration of
0.1 mM [40,41]. It is used in ALF solution to represent pro-
tein binding to foreign objects. Here the interaction of citrate
with AO nanowhiskers plays an important role in the nano-
material dissolution. The solutions of artificial biological
fluids are only facsimiles of actual lung fluids and some AO
nanowhiskers were likely cleared from the pulmonary system
after exposure. Thus, it is most likely that the nanomaterials
were not present in lung fluids for as long as they were
present in our simulated lung fluids for our dissolution stud-
ies (2 or 4 wks). Low solubility of AO nanowhiskers in epi-
thelial lining fluid was also confirmed by very low levels of
Al ions in supernatants of BAL fluid measured by ICP-MS.
There was significantly higher recruitment of alveolar
macrophages in BAL fluid with longer exposure to AO
nanowhiskers. However, the number of neutrophils and
lymphocytes were not elevated meaningfully. Thus, it
seemed that macrophages were able to control the aero-
sol load in the pulmonary system without upregulation
of cytokine production or cytotoxicity. The experimental
design with the total exposure period lasting up to
28 days would be sufficient for the mice to develop
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evaluation of the lung tissues as well as pulmonary
mechanics assessment found no pathological changes.
This may be attributed to the low fibrogenicity of the
material or low lung burden of AO nanowhisker in
exposed mice. These findings are consistent with our
measurements of total protein, LDH activity as well as
cytokines/chemokines measured in BAL fluid. We also
analyzed basic hematology parameters in the blood for
possible systemic effects of inhaled aerosol of AO nano-
whiskers, but did not find any deviations from our con-
trol animals.
A rat inhalation study of AlOOH with primary particle
range of 10 – 40 nm (with mass median aerodynamic
diameter (MMAD) of agglomerated particles in inhal-
ation chambers 1.7 and 0.6 μm, respectively) for 4 wks
(6 hrs/day, 5 days/wk), found significant pathology
changes in BAL parameters and lung pathology only at
the highest exposure concentration (28 mg/m3), but not
at concentrations of 0.4 and 3 mg/m3 [42]. Despite a
number of differences between Pauluhn and our study
(e.g. different animal models, morphology and size of
nanomaterials, and length of exposures) their findings
are noteworthy. Similarly, like our study, this study did
not find any substantial extrapulmonary translocation
of Al.
In our presented study, the estimated lung burden of
AO nanowhiskers per mouse after 2-wk-exposure was
19.6 μg/mouse and after 4-wk-exposure it was 39.2 μg/
mouse. We observed minimal pulmonary responses after
this exposure similarly as after sub-acute (2-wk) expos-
ure to silver (Ag) NPs with estimated lung burden of
29.4 μg/mouse [31]. On the other hand, in our previous
study of copper (Cu) NPs [32] we observed substantial
neutrophilic response after sub-acute exposure to Cu
NPs with estimated lung burden of 32 μg/mouse. Cer-
tainly, there are many physicochemical characteristics of
nanomaterials that play role in their toxicity (e.g. bulk
and surface chemical compositions, size, phase, propen-
sity for dissolution, ability for clearance or translocation
etc.) and they need to be taken into the consideration
when these materials are evaluated.
Our inhalation exposure to AO nanowhiskers did not
result in “frustrated phagocytosis” and subsequent in-
flammation, which might have been expected since
shorter fibers are more likely to be phagocytosed by al-
veolar macrophages than longer fibers. Another reason
might be that the AO nanowhiskers after generation to
the exposure chamber appeared more like tangled bun-
dles of materials rather than individual fibers. And thus
it is possible that they behaved more like particles that
could be cleared from respiratory system by the muco-
ciliary escalator. It appears that alveolar macrophages
in our study were not overloaded since we did notobserve an increased production of pro-inflammatory cyto-
kines/chemokines and subsequent higher recruitment of
neutrophils that would otherwise lead to pathologic out-
comes. Furthermore, AO nanowhiskers may have en-
dured some other changes after entering the respiratory
system, such as breakdown that might further increase
their clearance from pulmonary system.
A number of studies report that surface area of parti-
cles is associated with the magnitude of airway inflam-
mation [43-45]. The surface area of AO nanowhiskers
(320 ± 4 m2/g) was the largest of all nanomaterials stud-
ied thus far by our group [18,29-32]. Therefore and also
considering current knowledge about HARNs concern-
ing their toxicity, we hypothesized that there might be a
potential for a higher toxicity of this nanomaterial.
However, as in our previous study with two TiO2 nano-
particles with different surface areas [30] as well as other
studies [46,47], our results add the evidence that there
are many physicochemical properties of nanomaterials
that play a role in toxicity. Larger surface area of nano-
materials is only one consideration and is not always re-
sponsible for higher toxicity. Other studies have shown
that the shape of fibrous material has a decisive role
in their toxicity, however AO nanowhiskers that we
investigated exhibited low toxicity in this study. Cell sur-
face injury was observed in macrophages exposed to fi-
brous TiO2, but no significant changes in macrophages
were found in case of particulate TiO2 [48]. In vitro
study of carbon nanotubes and nanofibers found that
long, straight, well-dispersed nanofilaments caused sig-
nificantly higher production of TNF-α and reactive oxy-
gen species (ROS) in human peripheral blood
mononuclear cells than highly curved or tangled materi-
als [49].
Conclusions
A murine sub-chronic inhalation exposure consisting of
a dry aerosol of aluminum-oxide based nanowhiskers
caused increased recruitment of macrophages to the
lungs, but no inflammatory or toxic responses. It appears
that there was sufficient pulmonary clearance and AO
nanowhiskers did not cause inflammatory, cytotoxic or
immune responses, lung pathology, or changes in pul-
monary function in exposed mice. Considering primary
dimensions of studied material, large surface area as well
as low solubility in intracellular or extracellular simu-
lated biological fluids, one would predict higher bioper-
sistence of the material in the lungs with subsequent
toxicity similar to fibrous materials. However, the mass
of AO nanowhiskers retained in the lung represented
only about 4% of our estimated dose, thus we presume
that AO nanowhiskers were readily phagocytized by
macrophages probably because they were presented
more as tangled bundles rather than more crystalline
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